Skip to content

Collaborative Trial of Fluvastatin on Atrial Fibrillation

Collaborative Trial of Fluvastatin on Atrial Fibrillation - CO-FAT study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000582
Enrollment
300
Registered
2007-01-31
Start date
2007-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

paroxysmal atrial fibrillation or transient atrial fibrillation

Interventions

fluvastatin add-on therapy conventional therapy

Sponsors

CO-FAT study group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient who has either of the following atrial fibrillations: (1) paroxysmal atrial fibrillation (frequency of Af attack: over 2 times per month) (2) transient atrial fibrillation planned cardiovaersion 2) Outpatients aged over 20 years, regardless of sex 3) regardless of medication on atrial fibrillation 3) Total cholesterol over 220 mg/dL or LDL-cholesterol less than 140 mg/dL

Exclusion criteria

Exclusion criteria: 1) patients who underwent catheter ablation within 3 months 2) patients who underwent cardiac surgery within 1 month 3) patients with a history of cerebrovascular disorder or myocardial infarction within 1 month 4) patients with severe heart failure 5) patients with dialysis or severe renal dysfunction 6) patients with severe liver dysfunction 7) other patients who are judged to be inappropriate for the study by the investigator

Design outcomes

Primary

MeasureTime frame
1) maintenance of sinus rhythm 2) frequency of atrial fibrillation occurrence

Secondary

MeasureTime frame
1) new onset or recurrence of brain attack (including TIA) 2) hospitalization due to heart failure 3) other cardiovascular events 4) other adverse events

Countries

Japan

Contacts

Public ContactSachio Sekiguchi

University of Tsukuba, Graduate School of Comprehensive Human Science Department of Cardiology

029-853-2991

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026